MENU
EVMN
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Evommune (EVMN) Earnings Date & Reports
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases... Show more
A.I. Advisor
published Earnings
EVMN is expected to report earnings to rise 7.81% to -68 cents per share on September 02
Q2'26
Est.
$-0.69
Q1'26
Beat
by $0.12
The last earnings report on May 08 showed earnings per share of -63 cents, beating the estimate of -75 cents. With 118.65K shares outstanding, the current market capitalization sits at 812.21M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information